Square Jaw — Muscle or Bone, and Why It Matters

A wide lower face is two entirely different findings that look the same from across a room. One is muscle and it responds well to toxin; the other is bone and it does not respond to toxin at all — and the examination that separates them takes about fifteen seconds.

The Same Outline, Two Different Causes

The angle of the mandible sits just in front of and below the ear, and the masseter muscle runs from the zygomatic arch down to cover it. Width at that point can come from the muscle, from the bone beneath it, or from both in a ratio that varies from patient to patient. Looking at the face tells you the width; it does not tell you what is producing it.

This ambiguity is the reason jaw slimming injections disappoint some patients entirely. Toxin acts on the neuromuscular junction. It reduces the contraction of the muscle it is injected into and, through disuse, reduces the muscle's bulk. What it cannot do is alter the shape of the mandible, because bone has no neuromuscular junction to block.

So a patient whose width is predominantly skeletal can receive a technically perfect treatment, at an appropriate dose, in the correct plane, and see very little change — not because anything was done badly but because the target was never there. Square jaw and masseter hypertrophy is one diagnosis among two possibilities, and it is established by examination rather than by assumption.

The Clench And Palpate Examination

Place your fingertips over the angle of the jaw and clench your teeth firmly. A hypertrophic masseter announces itself — a defined mass firms under the fingers, bulges laterally, and softens again the moment the teeth part. The difference between the clenched and relaxed states is obvious to both patient and examiner.

Now do the same with a skeletally wide jaw. Something firms, because everyone has a masseter, but the underlying prominence does not change. The width you can feel with the jaw relaxed is essentially the width you feel when it is clenched, and the bony angle is palpable as a hard, fixed edge rather than a mobile mass.

Two supporting observations help. Muscle width is usually accompanied by a history — morning jaw tightness, tooth wear, a partner reporting grinding, dental appliances, or a diet with a great deal of chewing. Skeletal width has usually been present since adolescence and is visible in family photographs of relatives. A history that runs from childhood favours bone; one that developed in the twenties or thirties favours muscle.

Why Toxin Works On Muscle

Botulinum toxin blocks acetylcholine release at the neuromuscular junction, so the injected fibres cannot contract. A muscle that is not contracting is not being loaded, and a muscle that is not being loaded undergoes disuse atrophy in exactly the way any unused muscle does. The reduction in bulk is a secondary consequence of the block, not a direct effect of the drug.

That mechanism explains the timeline. The block itself takes effect within days, but there is very little visible narrowing at that point because the muscle is still the same size. Atrophy develops over the following weeks and the contour change becomes apparent from around six weeks, continuing to progress towards a stable appearance by around three months.

Patients who expect a visible jawline the week after treatment are measuring the wrong thing at the wrong time, and clinics that respond to that expectation with a higher dose are treating impatience rather than anatomy. The dose is set by the size and strength of the muscle on examination — jaw BTX and face slimming is planned on palpation, not on a standard number.

Why It Does Nothing For Bone

This section is short because the physiology is. Bone width at the mandibular angle is skeletal morphology. It is determined by growth and remodelling, it is not innervated in any way that toxin can influence, and no dose, no product and no injection technique reduces it.

The practical failure mode is escalation. A patient whose width is skeletal sees minimal change, reports this, and is offered a higher dose. The higher dose atrophies the masseter further without touching the bone, so the muscular cover over the angle thins and the bony prominence becomes, if anything, more sharply defined. The face becomes more angular rather than less.

The correct response to a poor result is therefore to re-examine rather than to increase. If the clench test shows a modest, well-behaved muscle over a broad bony angle, the honest statement is that the width is skeletal and that injectables are not the instrument for it. Saying that is considerably more useful than a fourth session.

Over-Treatment — The Hollow Cheek And The Chewing Problem

Repeated or excessive masseter treatment produces a recognisable appearance. The muscle atrophies beyond the point of slimming, and a concavity develops over the lateral lower face where the bulk used to be. Combined with any existing midface volume loss, this reads as gaunt rather than refined, and it is one of the harder over-treatment patterns to correct because the missing tissue is muscle.

Recovery is possible — the muscle regains bulk once treatment is stopped and normal loading resumes — but it takes several months and in the meantime the correction usually involves adding volume to a region that did not need volume. Hollow cheeks produced this way are avoidable by dosing to the examination rather than to a request.

There is a functional dimension as well. The masseter is a muscle of mastication, and substantially weakening it bilaterally reduces chewing efficiency, which patients notice with firmer foods. Compensatory recruitment of the temporalis and other masticatory muscles can follow, occasionally producing temporal fullness or headache. Neither effect is common at appropriate doses, and both become more likely as doses rise.

What Changes A Skeletally Wide Lower Face

Bone width can be addressed surgically. Mandibular angle reduction is a maxillofacial procedure performed under general anaesthesia with a real recovery and real risks, and for a patient whose width genuinely troubles them it is the only intervention that alters the structure itself. That referral is the accurate advice, and it is given rather than avoided.

Short of surgery, the available approach is proportion rather than reduction. A face reads as wide partly in relation to its other dimensions, so increasing projection at the chin lengthens and narrows the perceived lower third without touching the angles at all. Chin enhancement is frequently the single most effective non-surgical answer to a complaint about jaw width.

Submental fullness contributes too. A soft, undefined transition between chin and neck makes the lower face read as broad even where the bone is unremarkable, and treating that region sharpens the outline more convincingly than anything done at the angle. Submental fullness is assessed alongside the jaw rather than separately.

Timing, Relapse And Maintenance

The effect is not permanent. Nerve terminals sprout and recover, the muscle is loaded again, and bulk returns over months. Where the underlying driver is bruxism or habitual clenching, it returns reliably, because the behaviour that built the muscle has not changed. This is why the first treatment is presented as the beginning of a schedule rather than as a single event.

Intervals lengthen with repetition in many patients, since a muscle repeatedly held in disuse takes longer to rebuild. That is a reason to space treatments by the examination rather than by the calendar — re-palpating at review and treating when the muscle has genuinely returned, not on a fixed date.

Where clenching is the driver, addressing the clenching matters. Dental assessment for bruxism, a night guard where indicated, and attention to the daytime habit all reduce the rate of relapse. Treating the muscle without addressing what is loading it works, and it works less well and less durably than doing both — the broader indications are set out in masseter BTX.